Importance of higher infliximab trough level maintenance compared with the HLA-DQA1*05 polymorphism in preventing anti-infliximab antibodies and loss of response to infliximab
- DOI
- 10.1093/ibd/izag108
- Published
- 2026-06-23
- Container
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/ibd/izag108,
title = {Importance of higher infliximab trough level maintenance compared with the HLA-DQA1*05 polymorphism in preventing anti-infliximab antibodies and loss of response to infliximab},
author = {Joana Revés and Ana Guedes and Ana Catarina Bravo and Maria Sá and Pedro Viana Baptista and Alexandra Ramos Fernandes and Joana Torres},
year = {2026},
journal = {Inflammatory Bowel Diseases},
doi = {10.1093/ibd/izag108},
url = {https://doi.org/10.1093/ibd/izag108}
}RIS
TY - JOUR TI - Importance of higher infliximab trough level maintenance compared with the HLA-DQA1*05 polymorphism in preventing anti-infliximab antibodies and loss of response to infliximab AU - Joana Revés AU - Ana Guedes AU - Ana Catarina Bravo AU - Maria Sá AU - Pedro Viana Baptista AU - Alexandra Ramos Fernandes AU - Joana Torres PY - 2026 JO - Inflammatory Bowel Diseases DO - 10.1093/ibd/izag108 UR - https://doi.org/10.1093/ibd/izag108 ER -
APA
Revés, J., Guedes, A., Bravo, A. C., Sá, M., Baptista, P. V., Fernandes, A. R., & Torres, J. (2026). Importance of higher infliximab trough level maintenance compared with the HLA-DQA1*05 polymorphism in preventing anti-infliximab antibodies and loss of response to infliximab. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izag108
Source records
- crossref · retrieved 2026-11-05T22:55:57.199Z